As filed with the Securities and Exchange Commission on October 11, 2016

 

Registration No. 333-         

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

Form S-3

 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

 

EVINE Live Inc.

  (Exact name of registrant as specified in its charter)

 

 

 

    Minnesota   41-1673770

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

 

6740 Shady Oak Road

Eden Prairie, MN 55344-3433

(952) 943-6000

 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Damon E. Schramm

Senior Vice President, General Counsel and Secretary

EVINE Live Inc.

6740 Shady Oak Road

Eden Prairie, MN 55344-3433


(Address, including zip code, and telephone number, including area code, of agent for service)

Copies to :

 

J.C. Anderson, Esq.

Gray, Plant, Mooty, Mooty & Bennett, P.A.

500 IDS Center

80 South Eighth Steet

Minneapolis, MN 55402

(612) 632-3002

 

APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: From time to time after the effective date of this registration statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.   ¨

  

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.   x

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   ¨

 

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective on filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.   ¨

 

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.   ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer    ¨ Accelerated filer    x

Non-accelerated filer    ¨

   Smaller reporting company    ¨

   

(Do not check if a smaller
reporting company)  

 

 

CALCULATION OF REGISTRATION FEE

 

Title of each class of securities to be registered

Amount to be

Registered (1) (2) 

Proposed

Maximum offering price

per unit (3)

Proposed

maximum aggregate

offering price (3)(4)

Amount of

registration fee (3)

Common Stock, par value $0.01 per share 14,376,939 $2.16 $31,054,188.24 $3,599.18

  

(1) An estimated number of securities is being registered as may from time to time be offered at unspecified prices.  Includes common stock sold to the selling shareholders in the Private Placement, in addition to rights to acquire common stock of the Company under the Warrants, Options, and Option Warrants, all as further described in the sections titled “Description of Securities” and “Use of Proceeds.”
(2) Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement registers such indeterminate number of additional shares of common stock as may be issued in connection with stock splits, stock dividends or similar transactions.
(3) Estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(c), based on the average of the high and low prices for shares of the registrant’s common stock as reported on The NASDAQ Global Market on October 6, 2016.
(4) No separate consideration will be received for shares of common stock that are sold hereunder.  However, the Company will receive proceeds upon exercise of the Warrants, Options, and Option Warrants; provided that such proceeds will depend on the number of Warrants, Options and Option Warrants that are exercised, and the final exercise price of the Options and Option Warrants.  For more information, see the sections title “Description of Securities” and “Use of Proceeds.”

  

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

 

 

 

 

The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

  

Subject to Completion, dated October 11, 2016.

  

PROSPECTUS

 

 

EVINE Live Inc.

 

14,376,939 Shares of Common Stock

 

This prospectus relates to the sale by the selling shareholders identified in this prospectus, including their transferees, pledgees, donees, transferees or successors-in-interest, of up to an aggregate of 14,376,939 shares of our common stock, par value $0.01 per share, which includes (i) 5,952,381 shares issued to the selling shareholders; (ii) 2,976,190 shares issuable upon the exercise of warrants (“Warrants”); and (iii) an estimated 5,448,368 shares, of which two-thirds are issuable pursuant to the exercise of options (“Options”) and one-third is issuable upon exercise of additional warrants issuable upon exercise of the Options (“Option Warrants”). See the section titled “Description of Securities” beginning on page 9 of this prospectus for more information. The number of shares of common stock registered hereby that is issuable pursuant to the Options and underlying the Option Warrants is based on the Company’s common stock outstanding as of October 6, 2016. The common stock offered hereby was issued, or is issuable to the selling shareholders pursuant to Warrants or Options issued, in a private placement (the “Private Placement”) completed on September 19, 2016.

 

We are registering these securities on behalf of the selling shareholders, to be offered and sold by them from time to time. We are not selling any shares of common stock under this prospectus and will not receive any proceeds from the sale of the common stock offered by this prospectus. Any proceeds we receive from the exercise of Warrants, Options and Option Warrants will be used for general corporate purposes and debt repayment. It is anticipated that the selling shareholders will sell their shares of common stock from time to time in one or more transactions, in negotiated transactions or otherwise, at prevailing market prices or at prices otherwise negotiated (see the section titled “Plan of Distribution” beginning on page 14 of this prospectus). All expenses of registration incurred in connection with this offering are being borne by us, but all selling and other expenses incurred by the selling shareholders will be borne by the selling shareholders.

 

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements carefully before you make your investment decision.

 

Our common stock trades on the Nasdaq Global Market under the ticker symbol “EVLV.” On October 6, 2016, the closing price of our common stock was $2.14 per share.

 

Investing in these securities involves a high degree of risk. See “ Risk Factors ” beginning on page 7 of this prospectus, any prospectus supplement relating to an offer of securities and any document incorporated by reference herein or therein.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

 

The date of this prospectus is October 11, 2016.

 

 

 

 

TABLE OF CONTENTS

 

ABOUT THIS PROSPECTUS 1
WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE 1
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS 3
SUMMARY 5
RISK FACTORS 7
USE OF PROCEEDS 7
SELLING SHAREHOLDERS 7
DESCRIPTION OF SECURITIES 9
PLAN OF DISTRIBUTION 14
LEGAL MATTERS 16
EXPERTS 16

 

 

 

 

 

 

ABOUT THIS PROSPECTUS

 

When we refer to “we,” “us” or the “Company,” we mean EVINE Live Inc. and its subsidiaries unless the context indicates otherwise.

 

You should rely only on the information provided in this prospectus, any prospectus supplement and any free writing prospectus, including the information incorporated herein or therein by reference. Neither we nor the selling shareholders have authorized anyone to provide you with different information. You should not assume that the information in this prospectus, any prospectus supplement and any free writing prospectus is accurate at any date other than the date indicated on the cover page of such documents.

 

The distribution of this prospectus, any prospectus supplement and any free writing prospectus and the offering of the securities in certain jurisdictions may be restricted by law. Persons into whose possession this prospectus, any prospectus supplement and any free writing prospectus come should inform themselves about and observe any such restrictions. This prospectus, any prospectus supplement and any free writing prospectus does not constitute, and may not be used in connection with, an offer or solicitation by anyone in any jurisdiction in which such offer or solicitation is not authorized or in which the person making such offer or solicitation is not qualified to do so or to any person to whom it is unlawful to make such offer or solicitation.

 

This prospectus, any prospectus supplement and any free writing prospectus may include trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included in this prospectus, any prospectus supplement and any free writing prospectus are the property of their respective owners.

 

WHERE YOU CAN FIND MORE INFORMATION;
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

 

We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available over the Internet at the SEC’s web site at www.sec.gov. You may also read and copy any document we file with the SEC at its Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. We maintain a web site at www.evine.com. The information on our web site is not incorporated by reference in this prospectus, any prospectus supplement and any free writing prospectus, and you should not consider it a part of this prospectus, any prospectus supplement or any free writing prospectus.

 

The SEC allows us to “incorporate by reference” the information we file with them, which means that we can disclose important information to you by referring you to separate documents. The information incorporated by reference is considered to be part of this prospectus, any prospectus supplement and any free writing prospectus, and later information filed with the SEC will update and supersede this information. We incorporate by reference the documents listed below (other than information deemed furnished and not filed in accordance with SEC rules):

 

· Annual Report on Form 10-K for the fiscal year ended January 30, 2016;

 

· The portions of our Definitive Proxy Statement on Schedule 14A for the 2016 annual meeting that are incorporated by reference in our Annual Report on Form 10-K for the fiscal year ended January 30, 2016;

 

· Our Quarterly Reports on Form 10-Q for the three months ended April 30, 2016, filed on May 26, 2016, and for the three and six months ended July 30, 2016, filed on August 26, 2016;

 

· Current Reports on Form 8-K dated February 18, 2016; March 10, 2016; March 17, 2016; April 12, 2016; April 29, 2016; May 25, 2016; June 22, 2016; July 7, 2016; July 25, 2016; August 18, 2016; September 1, 2016; and September 14, 2016;

 

1

 

 

· The description of our common stock contained in the Registration Statement on Form 8-A filed with the SEC on May 22, 1992, as the same may be amended from time to time;

 

· The description of our Series A Junior Participating Cumulative Preferred Stock and the Shareholder Rights Agreement contained in our Registration Statement on Form 8-A, filed with the SEC on July 13, 2015, as the same may be amended from time to time;

 

· All documents filed by us with the SEC pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934, or the “Exchange Act,” after the date of the initial registration statement and prior to effectiveness of the registration statement shall be deemed to be incorporated by reference into the prospectus (except for information filed pursuant to Items 2.02 and 7.01 unless specifically deemed filed and not furnished in accordance with SEC rules); and

 

· All documents filed by us with the SEC pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act subsequent to the date of this prospectus and prior to the termination of this offering (except for information deemed furnished and not filed in accordance with SEC rules).

 

Copies of these filings are available at no cost on our website, www.evine.com. You may request a copy of these filings (other than an exhibit to a filing unless that exhibit is specifically incorporated by reference into that filing) at no cost, by writing to or telephoning us at the following address:

 

Corporate Secretary

EVINE Live Inc.

6740 Shady Oak Road

Eden Prairie, Minnesota 55344

(952) 943-6000

 

2

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus, any prospectus supplement delivered with this prospectus and the documents incorporated by reference herein and therein, may contain statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including statements regarding guidance, industry prospects or future results of operations or financial position made in this prospectus are forward-looking.

 

We often use words such as “may,” “will,” “could,” “estimates”, “continue,” “anticipates,” “believes,” “expects,” “intends” and similar expressions to identify forward-looking statements. These statements are based on management’s current expectations based on information currently available to us and accordingly are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained herein. Factors that could cause or contribute to such differences include, but are not limited to, those described in the “Risk Factors” section of our annual report on Form 10-K for the year ended January 30, 2016, our quarterly reports made after such date and other filings we have made with the SEC. These include, without limitation:

 

· macroeconomic issues, including, but not limited to, the general economic and the credit environment;

 

· risks relating to stagnant or decreased consumer spending and the level of consumer debt levels;

 

· the impact of increasing interest rates;

 

· risks relating to seasonal variations in consumer purchasing activities;

 

· risks relating to changes in the mix of products sold by us;

 

· competitive pressures on our sales, as well as pricing and sales margins;

 

· the level of cable and satellite distribution for our programming and the associated fees or estimated cost savings from contract renegotiations;

 

· our ability to continue to manage our cash, cash equivalents and investments to meet our liquidity needs;

 

· our ability to manage our operating expenses successfully and our working capital levels;

 

· our management and information systems infrastructure;

 

· changes in governmental or regulatory requirements;

 

· litigation or governmental proceedings affecting our operations;

 

· significant public events that are difficult to predict, such as widespread weather catastrophes or other significant television-covering events causing an interruption of television coverage or that directly compete with the viewership of our programming;

 

· our ability to obtain and retain key executives and employees;

 

· our ability to establish and maintain acceptable commercial terms with third-party vendors and other third parties with whom we have contractual relationships, and to successfully manage key vendor relationships and develop key partnerships and proprietary brands;

 

3

 

 

· our ability to successfully manage our new branding strategies related to our new EVINE Live brand and execute marketing initiatives, as well as customer acceptance of our new brand;

 

· our ability to attract new customers and retain existing customers;

 

· changes in shipping costs;

 

· our ability to offer new or innovative products and customer acceptance of the same;

 

· changes in customer viewing habits or television programming;

 

· our ability to remain compliant with our long-term credit facility covenants;

 

· the market demand for television station sales; and

 

· challenges to our data and information security.

 

Investors are cautioned that all forward-looking statements involve risk and uncertainty. The facts and circumstances that exist when any forward-looking statements are made and on which those forward-looking statements are based may significantly change in the future, thereby rendering the forward-looking statements obsolete. We are under no obligation (and expressly disclaim any obligation) to update or alter our forward-looking statements whether as a result of new information, future events or otherwise.

 

4

 

 

SUMMARY

 

The following summary contains basic information about us and this offering. It does not contain all of the information that you should consider in making your investment decision. You should read and consider carefully all of the information in this prospectus, including the information set forth under “Risk Factors,” any applicable prospectus supplement, as well as the more detailed financial information, including the consolidated financial statements and related notes thereto, appearing elsewhere or incorporated by reference in this prospectus, before making an investment decision. Unless the context indicates otherwise, all references in this prospectus to “EVINE,” “our,” “us” and “we” refer to EVINE Live Inc. and its subsidiaries as a combined entity.

 

Our Company

 

We are a digital commerce company that markets, sells and distributes products to consumers through TV, online, mobile and social media. We operate a 24-hour television shopping network, which is distributed primarily through cable and satellite affiliation agreements, through which we offer brand name and private label products in the categories of jewelry & watches; home & consumer electronics; beauty, health & fitness; and fashion & accessories. We also operate evine.com, a comprehensive digital commerce platform that sells products which appear on our television shopping channel as well as an extended assortment of online-only merchandise. Our programming and products are also marketed via mobile devices - including smartphones and tablets, and through the leading social media channels.

 

Our investor relations website address is evine.com/ir. Our goal is to maintain the investor relations website as a way for investors to easily find information about us, including press releases, announcements of investor conferences, investor and analyst presentations and corporate governance. We also make available free of charge our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and all amendments to these filings as soon as practicable after that material is electronically filed with or furnished to the SEC. The information found on our website is not part of this or any other report we file with, or furnish to, the SEC.

 

On November 18, 2014, we announced that we had changed our corporate name to EVINE Live Inc. Effective November 20, 2014, our NASDAQ trading symbol also changed from VVTV to EVLV. On February 14, 2015, we officially began using the new EVINE Live brand name and logo across television, online, mobile and social platforms.

 

EVINE Live Inc. is a Minnesota corporation with principal and executive offices located at 6740 Shady Oak Road, Eden Prairie, Minnesota 55344-3433. Our telephone number is (952) 943-6000.

 

5

 

 

The Offering

 

Common stock outstanding as of October 6, 2016     63,496,095  
         

Common stock offered by selling shareholders:

       
Currently issued and outstanding     5,952,381  
Issuable upon exercise of Warrants     2,976,190  
Issuable upon exercise of Options     3,632,245*  
Issuable upon exercise of Option Warrants     1,816,123*  
         
Total     14,376,939*  

Common stock outstanding assuming all Warrants, Options and Option Warrants are exercised

    71,920,653*  
         

*Shares issuable upon exercise the Options and Option Warrants are subject to change, as determined by the terms of the Option. Amounts listed are based on the number of common shares outstanding as of October 6, 2016. 

       
         
Use of Proceeds     We will not receive any proceeds from the sale of the common stock by the selling shareholders.  To the extent proceeds are received upon the exercise of the Warrants, Options and Option Warrants, we intend to use such proceeds for general working capital and debt repayment purposes.  
         
NASDAQ Symbol     Shares of our common stock are listed on the NASDAQ Global Market under the symbol “EVLV”.  
         
Risk Factors     See the section of this prospectus titled "Risk Factors" and the risk factors set forth in our most recent quarterly report on Form 10-Q and annual report on Form 10-K. You should carefully read and consider these risk factors together with all of the other information included in or incorporated by reference into this prospectus before you decide to purchase shares of our common stock.  

  

6

 

 

RISK FACTORS

 

An investment in our common stock involves risks. Before purchasing any shares of our common stock, consider carefully the risks together with all of the other information contained or incorporated by reference in this prospectus, including the risks described under the caption “Risk Factors” included in each of Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended January 30, 2016 and Part II, Item 1A of our Quarterly Report on Form 10-Q for the fiscal quarter ended July 30, 2016 and any subsequent Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q or Current Reports on Form 8-K we file after the date of this prospectus, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Securities Exchange Act of 1934, as amended, and the risk factors and other information contained in any applicable prospectus supplements before acquiring any of our common stock. We caution you that the risks and uncertainties we have described, among others, could cause our actual results to differ materially from those expressed in forward-looking statements made by us or on our behalf in filings with the SEC, press releases, communications with investors and oral statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.  

 

USE OF PROCEEDS

 

We will receive none of the proceeds from any sale or other disposition of the common stock covered by this prospectus. We would receive proceeds upon the cash exercise of the Warrants, Options and Option Warrants for which the underlying shares of common stock are being registered hereunder, although we cannot predict when or if such securities will be exercised. Assuming full cash exercise of the Warrants at the exercise price of $2.90 per share of common stock, the Options at an assumed exercise price of $2.22 per share and Option Warrants at an assumed exercise price of $3.21 per share (the exercise price for the Options and the Option Warrants is subject to change and has been calculated based on the stock prices current as of October 6, 2016, as further described in the section titled “Description of Securities” beginning on page 9 of this prospectus ), we will receive proceeds of approximately $22.5 million. We currently intend to use the cash proceeds from any Warrant, Option or Option Warrant exercise for general working capital and debt repayment purposes.

 

The amount and timing of our actual use of proceeds may vary significantly depending on the actual amount of proceeds we receive and the timing of when we receive such proceeds. In addition, the terms of the Warrants and Option Warrants provide that following January 17, 2016, they may be exercised on a cashless basis if at the time of exercise, the shares of common stock underlying the warrants are not subject to a registration statement or there has been a failure to maintain the effective registration of such shares. We will receive no cash proceeds from Warrants or Option Warrants that are exercised on a cashless basis under such terms of the Warrants and Option Warrants.

 

SELLING SHAREHOLDERS

 

The common stock being offered by each selling shareholder was issued to, or upon satisfaction of applicable exercise provisions will become issuable pursuant to the Warrants, Options and Option Warrants issued to, the selling shareholders on September 19, 2016, when we completed the Private Placement pursuant to separate securities purchase agreements with each selling shareholder dated as of September 14, 2016 (the “Purchase Agreements”). As set forth in the Purchase Agreements, we sold to certain “accredited investors” as defined in Rule 501(a) under the Securities Act pursuant to an exemption from registration under the Securities Act (the “selling shareholders”) an aggregate of (a) 5,952,381 shares of our common stock at a price of $1.68 per share, (b) Warrants to purchase 2,976,190 shares of common stock at an exercise price of $2.90 per share and (c) Options to purchase an assumed 3,632,245 shares of common stock at an assumed exercise price of $2.22 and to purchase Option Warrants to purchase an additional assumed 1,816,123 shares of common stock at an assumed exercise price of $3.21. The number of shares of common stock issuable upon exercise of an Option or Option Warrant, and the exercise price thereof, are to be determined in accordance with the terms of the Option or Option Warrant at the time of its exercise. Accordingly, the assumed number of shares issuable upon exercise of the Options and Option Warrants, and the assumed exercise price of the Options and Option Warrants, set forth above is an estimate based upon current assumptions as further described in t he section titled “Description of Securities” beginning on page 9 of this prospectus. We received total gross proceeds from the sale of the common stock, Warrants and Options to the selling shareholders of $10,000,000.

 

7

 

 

Each of the transactions by which the selling shareholders acquired their securities from us was exempt under the registration provisions of the Securities Act. Accordingly, the securities may not be offered or resold in the United States absent registration or an applicable exemption from registration. We are registering the common stock (including the common stock issuable pursuant to the exercise of the Warrants, Options and Option Warrants) pursuant to the registration statement of which this prospectus forms a part in order to permit the selling shareholders to offer such common stock for resale from time to time in accordance with the registration rights covenants set forth in their respective Purchase Agreements.

 

Upon closing of the Private Placement, Tommy Hilfiger (who is affiliated with TH Media Partners, LLC) and Thomas D. Mottola became members of the Company’s new Brand Building Advisory Committee, which is a non-board committee that will advise the Board of Directors, including on matters related to brand strategy. Except for such service, and the ownership of the shares of common stock, Warrants, Options and Option Warrants, the selling shareholders have not, within the past three years, had any other position, office or other material relationship with us. The information in the table below with respect to the selling shareholders has been obtained from the selling shareholders. When we refer to the “selling shareholders” in this prospectus, we mean the selling shareholders listed in the table below as offering securities, as well as their respective pledgees, donees, transferees or other successors-in-interest.

 

We do not know if, when or in what amounts the selling shareholders may offer their shares of common stock for sale. The selling shareholders may sell some, all or none of the shares offered by this prospectus. Because the number of shares the selling shareholders may offer and sell is not presently known, we cannot estimate the number of securities that will be held by each selling shareholder after completion of this offering. This table, however, presents the maximum number of shares of common stock that the selling stockholders may offer pursuant to this prospectus and the number of shares of common stock that would be beneficially owned after the sale of the maximum number of shares of common stock by each selling stockholder.

 

Beneficial ownership is determined under the rules of the SEC , and includes voting or investment power with respect to shares. In calculating the number of shares beneficially owned by an individual or entity and the percentage ownership of that individual or entity, shares underlying options or warrants that are either currently exercisable or exercisable within 60 days from the date of this prospectus are deemed outstanding. These shares, however, are not deemed outstanding for the purpose of computing the percentage ownership of any other individual or entity. In addition, unless otherwise indicated below, to our knowledge, each selling shareholder named in the table has sole voting and investment power with respect to the shares of common stock beneficially owned by it. The inclusion of any shares in this table does not constitute an admission of beneficial ownership for any selling shareholder named below.

 

    Number of Shares of Common Stock Owned Prior to Offering     Maximum Number of Shares of Common Stock to be Sold Pursuant to this Prospectus    

 

Shares of Common Stock Owned After Offering

 
Name of Selling Shareholder   Number (1)     Percent (2)     Number (3)     Percent (3)     Number (4)     Percent (4)  
Thomas D. Mottola     1,984,127       3.12 %     4,792,313       6.666 %     0       0 %
TH Media Partners, LLC     1,984,127       3.12 %     4,792,313       6.666 %     0       0 %
Morris Goldfarb     1,412,392       2.22 %     2,923,311       4.066 %     202,074       * %
Tower View LLC     595,238       *%       1,437694       2.000 %     0       0 %
Sammy Aaron     178,571       *%       431,308       0.600 %     0       0 %

 

*Less than 1%

                                               

 

8

 

 

 

(1) The number of shares reported in this column includes only shares beneficially owned by the selling shareholders and their affiliates prior to the date of this prospectus, including those shares sold in the Private Placement, but not including shares underlying the Warrants, Options, and Option Warrants.
(2) Based on 63,496,095 shares of our common stock outstanding on October 6, 2016.
(3) This number includes and assumes the maximum number of (a) those shares issuable upon exercise of the Warrants, (b) those shares issuable upon exercise of the Options and (c) those shares issuable upon exercise of the Option Warrants, all without regard to any limitation on exercise. Accordingly, the shares issuable upon exercise of the Warrants and the Option Warrants are not beneficially owned by the selling shareholders as of the date of this prospectus.  
(4) This number assumes the sale of all the shares offered by the selling shareholders and is calculated on a post-exercise basis.

  

DESCRIPTION OF SECURITIES

 

Our articles of incorporation provide that we may issue up to 100,000,000 shares of capital stock, par value $0.01 per share in the case of common stock, and having a par value as determined by the board of directors in the case of preferred stock. As of October 6, 2016, there were outstanding (i) 63,496,095 shares of common stock, (ii) Warrants to purchase an aggregate of 2,976,190 shares of common stock, and (iii) Options to purchase an assumed 3,632,245 shares of common stock and to purchase Option Warrants to purchase an additional assumed 1,816,123 shares of common stock (with the number of shares issuable pursuant to the Options and the Option Warrants based on the number of shares outstanding as of October 6, 2016, and therefore subject to change). In addition, as of October 6, 2016, there were 5,455,524 shares of common stock that may be issued upon the exercise of outstanding stock options (number includes both vested and non-vested stock options) issued pursuant to the Company’s 2011, 2004 and 2001 Incentive Stock Option Plans, and rights to purchase up to 400,000 shares of Series A Junior Participating Cumulative Preferred Stock.

 

Pursuant to the Purchase Agreement, we are required to register the shares of common stock sold in the Private Placement, as well as the shares of common stock issuable upon exercise of the Warrants, Options and Option Warrants (collectively, the “registrable securities”) for resale or other disposition. Specifically, we agreed to   (i) file with the SEC a shelf registration statement with respect to the resale of the registrable securities as soon as practicable after the closing of the Private Placement but within 30 days after the date of the Purchase Agreements; (ii) cause the shelf registration statement to be declared effective by the SEC as soon as possible after the initial filing, and in any event no later than 90 days after the closing date (or 120 days in the event of a full review of the shelf registration statement by the SEC); and (iii) keep the shelf registration statement effective until the earlier of the second anniversary of the closing, such time as all registrable securities may be sold pursuant to Rule 144 under the Securities Act of 1933 during any three-month period without the need for the Company to be in compliance with the current public information requirement of Rule 144 or such time as all registrable securities have been sold pursuant to an effective registration statement or Rule 144. If we are unable to comply with any of the above covenants, we will be required to pay liquidated damages to the selling shareholders in the amount of 1% of the selling shareholders’ purchase price for every 30 days until such non-compliance is cured (subject to a 12% cap), with such liquidated damages payable in cash.

 

A description of the material terms and provisions of our capital stock is set forth below. The description is intended as a summary and is qualified in its entirety by reference to our articles of incorporation and bylaws incorporated herein by reference. We have filed our articles of incorporation and bylaws as exhibits to the registration statement of which this prospectus is a part. You should read our articles of incorporation and bylaws for additional information before you buy any capital stock.

 

9

 

 

The following is a summary of the material features of our capital stock:

 

Common Stock

 

Holders of our common stock are entitled to one vote per share in the election of directors and on all other matters on which shareholders are entitled or permitted to vote. Holders of common stock are not entitled to cumulative voting rights. Subject to the terms of any outstanding series of preferred stock, the holders of common stock are entitled to dividends in amounts and at times as may be declared by the board of directors out of funds legally available therefor. Upon our liquidation or dissolution, holders of common stock are entitled to share ratably in all net assets available for distribution to shareholders after payment of any liquidation preferences to holders of preferred stock. Holders of common stock have no redemption, conversion or preemptive rights.

 

Pursuant to standstill agreements entered into by each selling shareholder as required by the Purchase Agreement, each of the selling shareholders agreed that for a period of 1 year from the closing date, such selling shareholder would not, individually or in concert with any group, purchase or otherwise acquire securities of the Company which would cause such selling shareholder, or the group with which such selling shareholder became associated, to beneficially own greater than 19.999% of the Company’s outstanding common stock.

 

Preferred Stock

 

Our articles of incorporation permit us to issue shares of preferred stock, from time to time, in one or more series and with such designation and preferences for each series as are stated in the resolutions providing for the designation and issue of each such series adopted by our board of directors. Our articles of incorporation authorize our board of directors to determine the number of shares, voting, dividend, redemption and liquidation preferences and limitations pertaining to such series. The board of directors, without shareholder approval, may issue preferred stock with voting rights and other rights that could adversely affect the voting power of the holders of our common stock and outstanding preferred stock could have certain anti-takeover effects. The ability of the board of directors to issue preferred stock without shareholder approval could have the effect of delaying, deferring or preventing a change in control of our company or the removal of existing management. We currently do not have shares of preferred stock outstanding; however, we have authorized up to 400,000 Series A Junior Participating Cumulative Preferred Stock,   $0.01   par value, in connection with the Shareholder Rights Plan described below, and pursuant to which we granted rights to purchase shares of the Series A Junior Participating Cumulative Preferred Stock . A description of the Series A Junior Participating Cumulative Preferred Stock can be found in our registration statement on Form 8-A filed on July 13, 2015.

 

Description of Warrants, Options and Option Warrants to Purchase Common Stock Pursuant to Which Common Stock May Be Issued

 

The Warrants entitle the holders to purchase up to an aggregate of 2,976,190 shares of common stock; provided, however, that such number is subject to adjustment due to the fact that each of the Warrants contains a limitation on the number of shares of common stock that a selling shareholder may purchase through the Private Placement. This limitation varies by selling shareholder, but the aggregate limitation, including all selling shareholders, prevents the securities offered in the Private Placement from exceeding 19.999% (including all common stock issued at the closing and the common stock issued following the exercise of all Warrants, Options and Option Warrants) of the sum of (i) the common stock outstanding prior to the Private Placement, plus (ii) the shares of common stock, and shares of common stock underlying the Warrants, purchased by all selling shareholders in the Private Placement, plus (iii) the shares of common stock underlying the Options and Option Warrants, purchased by all selling shareholders and assuming full exercise thereof.

 

The Warrants have an exercise price of $2.90 per share, which exercise price is subject to adjustment for stock splits, stock dividends, combinations or similar events. The Warrants will not be exercisable until March 20, 2017 and are exercisable until September 19, 2021.

 

The Options entitle the holders to purchase shares of common stock and to purchase Option Warrants pursuant to which shares of common stock are issuable. Such Options were not issued for a specific number of shares or Option Warrants; rather, each may be exercised for a combination, comprised of two-thirds shares of common stock and one-third Option Warrants, sufficient to increase such selling shareholder’s holdings in the Company, on a post-exercise basis, to a specific beneficial ownership percentage. This number varies by selling shareholder, but the aggregate of common stock issued at the closing and the Options and Option Warrants, if exercised in full by all selling shareholders, may not increase the holdings of all selling shareholders, collectively, to more than 19.999% of the Company’s 57,543,714shares of issued and outstanding common stock immediately prior to the Private Placement. The final number of shares of common stock each holder of an Option or an Option Warrant is entitled to purchase and the corresponding exercise price will be as described in the applicable prospectus supplement.

 

10

 

 

Each Option may only be exercised once, in whole or in part. The exercise price of an Option will be based on a per-share exercise price equal to the five-day volume weighted average price per share of the Company’s common stock as of the trading day immediately prior to exercise. For estimation purposes, assuming an exercise date of October 6, 2016, the exercise price of an Option would be $2.22 per share, subject to adjustment for stock splits, stock dividends, combinations or similar events. The term of each Option ends on March 19, 2017; provided, however, that each Option may not be exercised until October 19, 2016.

 

Each Option Warrant would be substantially in the form of Warrant issued in the Private Placement. The exercise price of an Option Warrant will be a price per share equal to a 50% premium to the Company’s closing stock price on the Nasdaq Global Market on the trading day most recently ended prior to the announcement of the exercise of the corresponding Option pursuant to which such Option Warrant was issued, subject to adjustment for stock splits, stock dividends, combinations or similar events. For estimation purposes, assuming that the corresponding Option exercise date was as of October 6, 2016, the exercise price of an Option Warrant would be $3.21. The term of each Option Warrant would be five years from the date of issuance and an Option Warrant may not be exercised for the first six months after issuance.

 

Provisions Regarding Aliens

 

Except as otherwise provided by law, not more than 20% of the aggregate voting power of all shares outstanding entitled to vote on any matter shall be at any time voted by or for the account of aliens as defined in the Communications Act of 1934, or their representatives, or by or for the account of a foreign government or representative thereof, or by or for the account of any corporation organized under the laws of a foreign country.

 

Except as otherwise provided by law, aliens, foreign governments, or corporations organized under the laws of a foreign country, or the representatives of such aliens, foreign governments, or corporations organized under the laws of a foreign country, shall not own, directly or through a third party who holds the stock for the account of such alien, foreign government, or corporation organized under the laws of a foreign country: (1) more than 20% of the number of shares of our outstanding stock, or (2) shares representing more than 20% of the aggregate voting power of all of our outstanding shares of voting stock.

 

Shares of stock shall not be transferable on our books to aliens, foreign governments, or corporations organized under the laws of foreign countries, or to the representatives of, or persons holding for the account of, such aliens, foreign governments, or corporations organized under the laws of foreign countries, unless, after giving effect to such transfer, the aggregate number of shares of stock owned by or for the account of aliens, foreign governments, and corporations organized under the laws of foreign countries, and any representatives thereof, will not exceed 20% of the number of shares of outstanding stock, and the aggregate voting power of such shares will not exceed twenty percent 20% of the aggregate voting power of all outstanding shares of our voting stock.

 

If, notwithstanding these restrictions on transfer, the aggregate number of shares of stock owned by or for the account of aliens, foreign governments, and corporations organized under the laws of foreign countries, exceed 20% of our shares of outstanding stock, or if the aggregate voting power of such shares exceed 20% of the aggregate voting power of all outstanding shares of our voting stock, we have the right to redeem shares of all classes of capital stock, at their then fair market value, on a pro rata basis, owned by or for the account of all aliens, foreign governments, and corporations organized under the laws of foreign countries, in order to reduce the number of shares and/or percentage of voting power held by or for the account of aliens, foreign governments, and corporations organized under the laws of foreign countries, and their representatives to the maximum number or percentage allowed under our articles of incorporation or as otherwise required by applicable federal law.

 

The board of directors shall make such rules and regulations as it deems necessary or appropriate to enforce the provisions of this section.

 

11

 

 

Anti-Takeover Provisions Contained in Our Articles of Incorporation, Shareholder Rights Plan and the Minnesota Business Corporation Act

 

Our shareholder rights plan, as well as certain provisions of our articles of incorporation and of Minnesota law described below could have an anti-takeover effect. These provisions are intended to provide management flexibility, to enhance the likelihood of continuity and stability in the composition of our board of directors and in the policies formulated by our board of directors and to discourage an unsolicited takeover of our company, if our board of directors determines that such a takeover is not in our best interests or the best interests of our shareholders. However, these provisions could have the effect of discouraging certain attempts to acquire us that could deprive our shareholders of opportunities to sell their shares of our stock at higher values.

 

Shareholder Rights Plan

 

During the second quarter of fiscal 2015, we adopted a shareholder rights plan to preserve the value of certain deferred tax benefits, including those generated by net operating losses. On July 10, 2015, we declared a dividend distribution of one purchase right (a “Right”) for each outstanding share of our common stock to shareholders of record as of the close of business on July 23, 2015 and issuable as of that date, and on July 13, 2015, we entered into a shareholder rights plan (the “Rights Plan”) with Wells Fargo Bank, N.A., a national banking association, with respect to the Rights. Except in certain circumstances set forth in the Rights Plan, each Right entitles the holder to purchase from us one onethousandth of a share of Series A Junior Participating Cumulative Preferred Stock, $0.01 par value, of the Company (“Preferred Stock” and each one onethousandth of a share of Preferred Stock, a “Unit”) at a price of $9.00 per Unit.

 

The Rights initially trade together with the common stock and are not exercisable. Subject to certain exceptions specified in the Rights Plan, the Rights will separate from the common stock and become exercisable following (i) the tenth calendar day after a public announcement or filing that a person or group has become an “Acquiring Person,” which is defined as a person who has acquired, or obtained the right to acquire, beneficial ownership of 4.99% or more of the common stock then outstanding, subject to certain exceptions, or (ii) the tenth calendar day (or such later date as may be determined by the board of directors) after any person or group commences a tender or exchange offer, the consummation of which would result in a person or group becoming an Acquiring Person. If a person or group becomes an Acquiring Person, each Right will entitle its holders (other than such Acquiring Person) to purchase one Unit at a price of $9.00 per Unit. A Unit is intended to give the shareholder approximately the same dividend, voting and liquidation rights as would one share of common stock, and should approximate the value of one share of common stock. At any time after a person becomes an Acquiring Person, the board of directors may exchange all or part of the outstanding Rights (other than those held by an Acquiring Person) for shares of common stock at an exchange rate of one share of common stock (and, in certain circumstances, a Unit) for each Right. We will promptly give public notice of any exchange (although failure to give notice will not affect the validity of the exchange).

 

The Rights will expire upon certain events described in the Rights Plan, including the close of business on the date of the third annual meeting of shareholders following the last annual meeting of our shareholders at which the Rights Plan was most recently approved by shareholders, unless the Rights Plan is re-approved by shareholders at that third annual meeting of shareholders. However, in no event will the Rights Plan expire later than the close of business on July 13, 2025. Until the close of business on the tenth calendar day after the day a public announcement or a filing is made indicating that a person or group has become an Acquiring Person, we may in our sole and absolute discretion amend the Rights or the Rights Plan agreement without the approval of any holders of the Rights or shares of common stock in any manner, including without limitation, amendments that increase or decrease the purchase price or redemption price or accelerate or extend the final expiration date or the period in which the Rights may be redeemed. We may also amend the Rights Plan after the close of business on the tenth calendar day after the day such public announcement or filing is made to cure ambiguities, to correct defective or inconsistent provisions, to shorten or lengthen time periods under the Rights Plan or in any other manner that does not adversely affect the interests of holders of the Rights. No amendment of the Rights Plan may extend its expiration date.

 

12

 

 

Statutory Provisions

 

Section 302A.671 of the Minnesota Business Corporation Act applies, with certain exceptions, to any acquisitions of our voting stock from a person other than us, and other than in connection with certain mergers and exchanges to which we are a party and certain tender offers or exchange offers approved in advance by a disinterested board committee, resulting in the beneficial ownership of 20% or more of the voting power of our then outstanding stock. Section 302A.671 requires approval of the granting of voting rights for the shares received pursuant to any such acquisitions by a vote of our shareholders holding a majority of the voting power of our outstanding shares and a majority of the voting power of our outstanding shares that are not held by the acquiring person, our officers or those non-officer employees, if any, who are also our directors. Similar voting requirements are imposed for acquisitions resulting in beneficial ownership of 33-1/3% or more or a majority of the voting power of our then outstanding stock. In general, shares acquired without this approval are denied voting rights in excess of the 20%, 33-1/3% or 50% thresholds and, to that extent, can be called for redemption at their then fair market value by us within 30 days after the acquiring person has failed to deliver a timely information statement to us or the date our shareholders voted not to grant voting rights to the acquiring person’s shares.

 

Section 302A.673 of the Minnesota Business Corporation Act generally prohibits any business combination by us, or any subsidiary of ours, with any shareholder that beneficially owns 10% or more of the voting power of our outstanding shares (an “interested shareholder”) within four years following the time the interested shareholder crosses the 10% stock ownership threshold, unless the business combination is approved by a committee of disinterested members of our board of directors before the time the interested shareholder crosses the 10% stock ownership threshold.

 

Section 302A.675 of the Minnesota Business Corporation Act generally prohibits an offeror from acquiring our shares within two years following the offeror’s last purchase of our shares pursuant to a takeover offer with respect to that class, unless our shareholders are able to sell their shares to the offeror upon substantially equivalent terms as those provided in the earlier takeover offer. This statute will not apply if the acquisition of shares is approved by a committee of disinterested members of our board of directors before the purchase of any shares by the offeror pursuant to the earlier takeover offer.

 

Authorized But Unissued Shares of Common Stock and Preferred Stock

 

Our authorized but unissued shares of common stock and preferred stock are available for our board of directors to issue without shareholder approval. We may use these additional shares for a variety of corporate purposes, including future public offerings to raise additional capital, corporate acquisitions and employee benefit plans. In addition, our articles of incorporation permit us to issue shares of preferred stock, from time to time, in one or more series and with such designation and preferences for each series as are stated in the resolutions providing for the designation and issue of each such series adopted by our board of directors. Our articles of incorporation authorize our board of directors to determine the number of shares, voting, dividend, redemption and liquidation preferences and limitations pertaining to such series. The board of directors, without shareholder approval, may issue common stock or preferred stock with voting rights and other rights that could adversely affect the voting power of the holders of our common stock could have certain anti-takeover effects. We currently do not have any shares of preferred stock outstanding and have no present plans to issue any shares of preferred stock. The ability of the board of directors to issue common stock or preferred stock without shareholder approval could have the effect of delaying, deferring or preventing a change in control of our company or the removal of existing management.

 

Transfer Agent and Registrar

 

Wells Fargo Shareowner Services has been appointed as the transfer agent and registrar for our common stock.

 

Listing

 

Our common stock is quoted on the Nasdaq Global Market under the symbol “EVLV.”

 

13

 

 

Limitation of Liability and Indemnification Matters

 

We are subject to Minnesota Section 302A.521, which provides that a corporation shall indemnify any person made or threatened to be made a party to a proceeding by reason of the former or present official capacity (as defined in Section 302A.521 of the Minnesota Statutes) of that person against judgments, penalties, fines, including, without limitation, excise taxes assessed against such person with respect to an employee benefit plan, settlements and reasonable expenses, including attorneys’ fees and disbursements, incurred by such person in connection with the proceeding, if, with respect to the acts or omissions of that person complained of in the proceeding, that person:

 

· has not been indemnified therefor by another organization or employee benefit plan;

 

· acted in good faith;

 

· received no improper personal benefit and Section 302A.255 (with respect to director conflicts of interest), if applicable, has been satisfied;

 

· in the case of a criminal proceeding, had no reasonable cause to believe the conduct was unlawful; and

 

· in the case of acts or omissions occurring in such person’s performance in an official capacity, such person must have acted in a manner such person reasonably believed was in the best interests of the corporation or, in certain limited circumstances, not opposed to the best interests of the corporation.

 

In addition, Section 302A.521, subdiv. 3 requires payment by the registrant, upon written request, of reasonable expenses in advance of final disposition in certain instances. A decision as to required indemnification is made by a majority of the disinterested board of directors present at a meeting at which a disinterested quorum is present, or by a designated committee of disinterested directors, by special legal counsel, by the disinterested shareholders, or by a court.

 

Our bylaws provide that we will indemnify any of our officers, directors, employees, and agents to the fullest extent permitted by Minnesota law and we have indemnification agreements with our directors and officers.

 

We have a director and officer liability insurance policy to cover us, our directors and our officers against certain liabilities.

 

PLAN OF DISTRIBUTION

 

We are registering for resale the shares of common stock issued to the selling shareholders and issuable upon exercise of the Warrants, Options and Option Warrants issued to the selling shareholders and certain transferees. We will not receive any of the proceeds from the sale by the selling shareholders of the shares of common stock, although we may receive proceeds upon the exercise of the Warrants, Options and Option Warrants by the selling shareholders. We will bear all fees and expenses incident to our obligation to register the shares of common stock. If the shares of common stock are sold through broker-dealers or agents, the selling shareholder will be responsible for any compensation to such broker-dealers or agents.

 

The selling shareholders may pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time pursuant to this prospectus.

 

The selling shareholders also may transfer and donate the shares of common stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.

 

14

 

 

The selling shareholders will sell their shares of common stock subject to the following:

 

· all of a portion of the shares of common stock beneficially owned by the selling shareholders or their perspective pledgees, donees, transferees or successors in interest, may be sold on the OTC Bulletin Board Market, any national securities exchange or quotation service on which the shares of our common stock may be listed or quoted at the time of sale, in the over-the counter market, in privately negotiated transactions, through the writing of options, whether such options are listed on an options exchange or otherwise, short sales or in a combination of such transactions;

 

· each sale may be made at market price prevailing at the time of such sale, at negotiated prices, at fixed prices or at carrying prices determined at the time of sale;

 

· some or all of the shares of common stock may be sold through one or more broker-dealers or agents and may involve crosses, block transactions or hedging transactions. The selling shareholders may enter into hedging transactions with broker-dealers or agents, which may in turn engage in short sales of the common stock in the course of hedging in positions they assume. The selling shareholders may also sell shares of common stock short and deliver shares of common stock to close out short positions or loan or pledge shares of common stock to broker-dealers or agents that in turn may sell such shares;

 

· in connection with such sales through one or more broker-dealers or agents, such broker-dealers or agents may receive compensation in the form of discounts, concessions or commissions from the selling shareholders and may receive commissions from the purchasers of the shares of common stock for whom they act as broker-dealer or agent or to whom they sell as principal (which discounts, concessions or commissions as to particular broker-dealers or agents may be in excess of those customary in the types of transaction involved). Any broker-dealer or agent participating in any such sale may be deemed to be an “underwriter” within the meaning of the Securities Act and will be required to deliver a copy of this prospectus to any person who purchases any share of common stock from or through such broker-dealer or agent. We have been advised that, as of the date hereof, none of the selling shareholders have made any arrangements with any broker-dealer or agent for the sale of their shares of common stock; and

 

· in connection with any other sales or transfers of common stock not prohibited by law.

 

The selling shareholders and any broker-dealer participating in the distribution of the shares of common stock may be deemed to be “underwriters” within the meaning of the Securities Act, and any profits realized by the selling shareholders and any commissions paid, or any discounts or concessions allowed to any such broker-dealer may be deemed to be underwriting commissions or discounts under the Securities Act. In addition, any shares of common stock covered by this prospectus which qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to this prospectus. A selling shareholder may also transfer, devise or gift the shares of common stock by other means not covered in this prospectus in which case the transferee, devisee or giftee will be the selling shareholder under this prospectus.

 

If required at the time a particular offering of the shares of common stock is made, a prospectus supplement or, if appropriate, a post-effective amendment to the shelf registration statement of which this prospectus is a part, will be distributed which will set forth the aggregate amount of shares of common stock being offered and the terms of the offering, including the name or names of any broker-deals or agents, any discounts, commissions or concessions allowed or reallowed or paid to broker-dealers.

 

Under the securities laws of some states, the shares of common stock may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states the shares of common stock may not be sold unless such shares have been registered or qualified for sale in such state or an exemption from registration or qualification is available and is complied with. There can be no assurance that any selling shareholder will sell any or all of the shares of common stock registered pursuant to the shelf registration statement, of which this prospectus forms a part.

 

15

 

 

The selling shareholders and any other person participating in such distribution will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including, without limitation, Regulation M of the Exchange Act, which may limit the timing of purchases and sales of any of the shares of common stock by the selling shareholders and any other participating person. Regulation M may also restrict the ability of any person engaged in the distribution of the shares of common stock to engage in market-making activities with respect to the shares of common stock. All of the foregoing may affect the marketability of the shares of common stock and the ability of any person or entity to engage in market-making activities with respect to the shares of common stock.

 

We will bear all expenses of the registration of the shares of common stock including, without limitation, Securities and Exchange Commission filing fees and expenses of compliance with the state securities of “blue sky” laws. The selling shareholders will pay all underwriting discounts and selling commissions and expenses, brokerage fees and transfer taxes, as well as the fees and disbursements of counsel to and experts for the selling shareholders, if any. We will indemnify the selling shareholders against liabilities, including some liabilities under the Securities Act, in accordance with the registration rights agreement or the selling shareholder will be entitled to contribution. We will be indemnified by the selling shareholders against civil liabilities, including liabilities under the Securities Act that may arise from any written information furnished to us by the selling shareholders for use in this prospectus, in accordance with the related securities purchase agreement or will be entitled to contribution. Once sold under this shelf registration statement, of which this prospectus forms a part, the shares of common stock will be freely tradable in the hands of persons other than our affiliates.

 

LEGAL MATTERS

 

Gray, Plant, Mooty, Mooty & Bennett, P.A, Minneapolis, Minnesota, will issue an opinion about the legality of the securities offered under this prospectus. Any underwriters will be represented by their own legal counsel.

 

EXPERTS

 

The consolidated financial statements, and the related consolidated financial statement schedule, incorporated in this prospectus by reference from our Annual Report on Form 10-K for the year ended January 30, 2016, and the effectiveness of our internal control over financial reporting have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their reports, which are incorporated herein by reference. Such financial statements and financial statement schedule have been so incorporated in reliance upon the reports of such firm given upon their authority as experts in accounting and auditing. 

 

16

 

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 14. Other Expenses of Issuance and Distribution

 

The following table sets forth the various expenses to be incurred in connection with the sale and distribution of the securities being registered hereby, all of which will be borne by the Company (except any underwriting discounts and commissions and expenses incurred by the selling shareholders for brokerage or legal services or any other expenses incurred by the selling stockholders in disposing of the shares). All amounts shown are estimates except the SEC registration fee.

 

SEC registration fee   $ 3,599.18  
Legal fees and expenses   $ 25,000  
Accounting fees and expenses   $ 5,000  
Miscellaneous   $ 2,000  
Total   $

35,599.18

 

 

Item 15. Indemnification of Directors and Officers

 

We are subject to the Minnesota Business Corporation Act (the “MBCA”). Section 302A.521 of the MBCA provides that we shall indemnify a person made or threatened to be made a party to a proceeding by reason of the former or present official capacity of such person against judgments, penalties, fines, including, without limitation, excise taxes assessed against such person with respect to any employee benefit plan, settlements and reasonable expenses, including attorneys’ fees and disbursements, incurred by such person in connection with the proceeding, if, with respect to the acts or omissions of such person complained of in the proceeding, such person:

 

· has not been indemnified by another organization or employee benefit plan for the same judgments, penalties, fines, including, without limitation, excise taxes assessed against the person with respect to an employee benefit plan, settlements, and reasonable expenses, including attorneys’ fees and disbursements, incurred by the person in connection with the proceeding with respect to the same acts or omissions;

 

· acted in good faith;

 

· received no improper personal benefit and Section 302A.255 of the MBCA, if applicable, has been satisfied;

 

· in the case of a criminal proceeding, had no reasonable cause to believe the conduct was unlawful; and

 

· in the case of acts or omissions occurring in such person’s performance in an official capacity, such person must have acted in a manner such person reasonably believed was in our best interests, or, in certain limited circumstances, not opposed to our best interests.

 

In addition, Section 302A.521, subdivision 3 requires payment by the registrant, upon written request, of reasonable expenses in advance of final disposition in certain instances. A decision as to required indemnification is made by a majority of the disinterested board of directors present at a meeting at which a disinterested quorum is present, or by a designated committee of disinterested directors, by special legal counsel, by the disinterested shareholders, or by a court.

 

Our bylaws provide that we will indemnify any of our officers, directors, employees, and agents to the fullest extent permitted by Minnesota law and we have indemnification agreements with our directors and officers.

 

We have a director and officer liability insurance policy to cover us, our directors and our officers against certain liabilities.

 

II- 1

 

 

Item 16. Exhibits

 

(a) Exhibits

 

A list of exhibits filed with this registration statement on Form S-3 is set forth on the Exhibit Index and is incorporated herein by reference.

 

Item 17. Undertakings

 

(a) The undersigned registrant hereby undertakes:

 

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

 

(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement; and

 

(iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

 

provided , however , that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is a part of the registration statement.

 

(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

II- 2

 

 

(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

 

(i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

 

(ii) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided , however , that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

 

(b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(h) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

  

II- 3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Eden Prairie, Minnesota, on the 11th day of October, 2016.

 

    EVINE Live Inc.
   
   
  By:    /s/ Robert Rosenblatt
    Robert Rosenblatt
   

Chief Executive Officer

(Principal Executive Officer)

  

POWER OF ATTORNEY

 

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Robert Rosenblatt, Timothy Peterman or Damon E. Schramm, or any of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to file and sign any and all amendments, including post-effective amendments and any registration statement for the same offering that is to be effective under Rule 462(b) of the Securities Act, to this registration statement, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

 

 

SIGNATURE

 

TITLE

 

DATE

     

/s/ Robert Rosenblatt

Robert Rosenblatt

 

Chief Executive Officer and Director

(Principal Executive Officer)

  October 11, 2016
     

/s/ Timothy Peterman

Timothy Peterman

 

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

  October 11, 2016
     

/s/ Landel C. Hobbs

Landel C. Hobbs

  Chairman of the Board   October 11, 2016
         

/s/ Thomas Beers

Thomas Beers

  Director   October 11, 2016
         

/s/ Neal Grabell

Neal Grabell

  Director   October 11, 2016
         

/s/ Lisa Letizio

Lisa Letizio

  Director   October 11, 2016
         

/s/ Lowell Robinson

Lowell Robinson

  Director   October 11, 2016
         

/s/ Fred Siegel

Fred Siegel

  Director   October 11, 2016

 

 

 

 

EXHIBIT INDEX

 

Exhibit

Number

 

Description

4.1  

Amended and Restated Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on November 18, 2014). 

     
4.2  

Amended and Restated By-Laws, as amended through June 18, 2014 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 20, 2014). 

     
4.3  

Shareholder Rights Plan dated July 13, 2015 between the Company and Wells Fargo Bank, N.A. (incorporated by reference to Appendix A to the Company’s Proxy Statement filed on May 13, 2015). 

     
4.4   Form of Securities Purchase Agreement, including Form of Warrant and Form of Option, dated as of September 14, 2016 by and between EVINE Live Inc. and the purchasers referenced therein (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form  8-K, filed with the SEC on September 15, 2016).
   
4.5   Form of Specimen Certificate Representing Common Stock (incorporated by reference to Exhibit 4.9 on the Company’s Current Report on Form 8-K, filed with the SEC on June 9, 2010).
   
5.1   Opinion of Gray, Plant, Mooty, Mooty & Bennett, P.A.
   
23.1   Consent of Gray, Plant, Mooty, Mooty & Bennett, P.A. (included in Exhibit 5.1).
   
23.2   Consent of Deloitte & Touche LLP, independent registered public accounting firm.
   
24.1   Powers of Attorney (incorporated by reference to the signature page hereto).

 

 

 

Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Evolv Technologies Charts.
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Evolv Technologies Charts.